Pathology cell injury

Subdecks (8)

Cards (226)

  • General pathology studies the basic reactions of cells and tissues to abnormal stimuli and inherited defects that underlie all diseases.
  • Special or systemic pathology studies specific responses of specialized organs and tissues which are responsible for disorders.
  • Etiology, a core aspect of disease process, is the cause of a disease.
  • Clinical manifestations are the functional consequences of these changes.
  • Genetic etiology involves inherited mutations and disease-associated gene variants, or polymorphisms.
  • Acquired etiology can be infectious, nutritional, chemical, or physical.
  • Idiopathic disease is a disease of unknown cause.
  • Pathogenesis is the sequence of cellular, biochemical, and molecular events that follow the exposure of cells or tissues to an injurious agent.
  • Metaplasia is a condition where one differentiated cell type is replaced by another cell type, often changing from cells sensitive to stress into cells able to withstand an adverse environment.
  • Reduction in size of uterus after parturition is a pathologic condition known as Atrophy.
  • Fatty Change is characterized by lipid vacoules.
  • Liquefactive Necrosis is characterized by the digestion of the dead cells, focal bacterial or, occasionally, fungal infections, and Pus - creamy yellow necrotic material.
  • Cellular Swelling (Hydropic Change/Vacoular Degeneration) is the first manifestation of almost all forms of injury to cells.
  • Coagulative Necrosis is characterized by the architecture of dead tissues being preserved, affected tissues exhibiting a firm texture, and the injury denaturing not only structural proteins but also enzymes and so blocking the proteolysis of the dead cells.
  • Fat Necrosis is characterized by focal areas of fat destruction, from the release of activated pancreatic lipases, acute pancreatitis (fat saponification), and Ghost fat cells, calcium deposits, inflammation.
  • Caseous Necrosis is characterized by foci of tuberculous infection, a friable white appearance of the area of necrosis, and granuloma.
  • sequence of cellular, biochemical, and molecular events that follow the exposure of cells or tissues to an injurious agent— pathogenesis
  • General – studies basic reactions of cells and tissues to abnormal stimuli and inherited defect that underlie all diseases
  • Genetic - inherited mutations and disease- associated gene variants, or polymorphisms
  • Acquired - infectious, nutritional, chemical, physical
  • Multifactorial - arise from the effects of various external triggers on a genetically susceptible individual (atherosclerosis, cancer)
  • A symptom is a feeling which is noticed by a patient, indicating the presence of disease or abnormality.
  • A sign is a manifestation that is noted by an observer
  • Hypertrophy
    • Increase in size of cells→ increase in size of organ
  • Hyperplasia
    • Increase in the number of cells in an organ or
    tissue→increased mass of the organ or tissue
  • Atrophy - Reduced metabolic needs of the cells sufficient for it to survive
  • Metaplasia
    • One differentiated cell type (epithelial or mesenchymal) is replaced by another cell type
  • columnar to squamous -most common
    epithelial metaplasia
  • Barrett’s esophagus→intestinal metaplasia
  • Cellular Swelling (Hydropic Change/Vacoular Degeneration) - first manifestation of almost all forms of injury to cells
  • Irreversible Cell Injury
    • denaturation of intracellular proteins and enzymatic digestion of the lethally injured cell
  • Coagulative Necrosis architecture of dead tissues is preserved
    • affected tissues exhibit a firm texture
  • Liquefactive Necrosis
    • digestion of the dead cells
    • Pus-creamy yellow necrotic material
  • Liquefactive Necrosis
    • focal bacterial or, occasionally, fungal infections
  • Caseous Necrosis (cheeselike)
    • foci of tuberculous infection
    • friable white appearance of the area of necrosis
    • granuloma
  • Fat Necrosis
    • focal areas of fat destruction
    • from release of activated pancreatic lipase